stockrowCME Group Inc.
CME Financial Financial Data & Stock Exchanges
CME Group Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.5 billion, up 6.37% from fiscal 2024.
- Revenue
- +0.84%
- EPS
- +2.85%
- Free cash flow
- −11.2%
- Total debt
- +0.11%
Quarter to June 2026, against a year earlier
Follow CME
Alert me
CME Group Inc. (CME) EPS (diluted)
CME Group Inc.'s EPS (diluted) for fiscal 2025 was $11.16, up 15.4% from $9.67 in fiscal 2024. Over the twelve months to 30 June 2026 it was $11.79. Over the past ten years it has ranged from $3.69 (fiscal 2015) to $11.94 (fiscal 2017); the current reading is higher than 91% of that period. EPS (diluted) has risen for 5 consecutive fiscal years. CME Group Inc. ranks 6th of 14 Financial Data & Stock Exchanges companies by EPS (diluted).
EPS (diluted), annual
Embed this chart
Annual newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| FY2025 | $11.16 | 15.41% |
| FY2024 | $9.67 | 9.14% |
| FY2023 | $8.86 | 19.73% |
| FY2022 | $7.40 | 1.51% |
| FY2021 | $7.29 | 24.19% |
| FY2020 | $5.87 | (0.68%) |
| FY2019 | $5.91 | 3.50% |
| FY2018 | $5.71 | (52.18%) |
| FY2017 | $11.94 | 163.58% |
| FY2016 | $4.53 | 22.76% |
Quarterly newest first
| Period | EPS (diluted) | Change |
|---|---|---|
| Jun 2026 | $2.88 | (9.43%) |
| Mar 2026 | $3.18 | (1.85%) |
| Dec 2025 | $3.24 | 30.12% |
| Sep 2025 | $2.49 | (11.39%) |
| 42 more quarters | Free account |
Against its own ten years
EPS (diluted) against peers
| Company | EPS (diluted) |
|---|---|
| MSCI MSCI Inc compare | $18.28 |
| SPGI S&P Global Inc. compare | $16.38 |
| MCO Moody's Corporation compare | $15.77 |
| CBOE Cboe Global Markets, Inc. compare | $12.83 |
| CME CME Group Inc. | $11.79 |
| ICE Intercontinental Exchange Inc. compare | $7.08 |
| TRU TransUnion compare | $3.79 |
| NDAQ Nasdaq, Inc. compare | $3.43 |
| COIN Coinbase Global, Inc. compare | −$3.84 |
What EPS (diluted) is
Diluted EPS tells an investor how much profit a company earned for each share, counting the extra shares that options and convertible securities could create.
Reported line item
More on CME
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- The full statement